{
    "id": 26974,
    "fullName": "BRCA1 W1782*",
    "impact": "nonsense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "BRCA1 W1782* results in a premature truncation of the Brca1 protein at amino acid 1782 of 1863 (UniProt.org). W1782* has not been characterized, however, other BRCT domain deletion mutants downstream of W1782 are destablizing (PMID: 14534301), thus W1782* is predicted to lead to a loss of Brca1 protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 2590,
                    "pubMedId": 14534301,
                    "title": "Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/14534301"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 672,
        "geneSymbol": "BRCA1",
        "terms": [
            "BRCA1",
            "BRCAI",
            "BRCC1",
            "BROVCA1",
            "FANCS",
            "IRIS",
            "PNCA4",
            "PPP1R53",
            "PSCP",
            "RNF53"
        ]
    },
    "variant": "W1782*",
    "createDate": "09/08/2017",
    "updateDate": "09/08/2017",
    "referenceTranscriptCoordinates": {
        "id": 156239,
        "transcript": "NM_007294",
        "gDna": "chr17:g.43049182C>T",
        "cDna": "c.5345G>A",
        "protein": "p.W1782*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12056,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, an ovarian carcinoma patient harboring a BRCA1 W1782* germline mutation demonstrated stable disease when treated with Rubraca (rucaparib) (PMID: 28588062).",
            "molecularProfile": {
                "id": 28325,
                "profileName": "BRCA1 W1782*"
            },
            "therapy": {
                "id": 906,
                "therapyName": "Rucaparib",
                "synonyms": null
            },
            "indication": {
                "id": 4001,
                "name": "ovarian carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 9883,
                    "pubMedId": 28588062,
                    "title": "Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28588062"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28325,
            "profileName": "BRCA1 W1782*",
            "profileTreatmentApproaches": [
                {
                    "id": 17878,
                    "name": "PARP-1 Inhibitor",
                    "profileName": "BRCA1 W1782*"
                },
                {
                    "id": 17879,
                    "name": "PARP Inhibitor (Pan)",
                    "profileName": "BRCA1 W1782*"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 156239,
            "transcript": "NM_007294",
            "gDna": "chr17:g.43049182C>T",
            "cDna": "c.5345G>A",
            "protein": "p.W1782*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}